These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

248 related items for PubMed ID: 35411470

  • 1. Pathologic outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer: a meta-analysis of 26 studies.
    Li L, Wang T, Hu D, Wu D, Bi L, Luo Y, Guo Y, Yang X.
    Int J Colorectal Dis; 2022 May; 37(5):1063-1071. PubMed ID: 35411470
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Safety and prognosis analysis of transanal total mesorectal excision versus laparoscopic mesorectal excision for mid-low rectal cancer].
    Sun R, Cong L, Qiu HZ, Lin GL, Wu B, Niu BZ, Sun XY, Zhou JL, Xu L, Lu JY, Xiao Y.
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Jun 25; 25(6):522-530. PubMed ID: 35754217
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Comparison of pathological outcomes after transanal versus laparoscopic total mesorectal excision: a prospective study using data from randomized control trial.
    Zeng Z, Luo S, Chen J, Cai Y, Zhang X, Kang L.
    Surg Endosc; 2020 Sep 25; 34(9):3956-3962. PubMed ID: 31586244
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Laparoscopic total mesorectal excision versus transanal total mesorectal excision for mid and low rectal cancer: A systematic review and meta-analysis.
    Yi Chi Z, Gang O, Xiao Li F, Ya L, Zhijun Z, Yong Gang D, Dan R, Xin L, Yang L, Peng Z, Yi L, Dong L, De Chun Z.
    Medicine (Baltimore); 2024 Jan 26; 103(4):e36859. PubMed ID: 38277570
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pathological outcomes of transanal versus laparoscopic total mesorectal excision for rectal cancer: a systematic review with meta-analysis.
    Jiang HP, Li YS, Wang B, Wang C, Liu F, Shen ZL, Ye YJ, Wang S.
    Surg Endosc; 2018 Jun 26; 32(6):2632-2642. PubMed ID: 29464401
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Transanal Versus Laparoscopic Total Mesorectal Excision: A Comparative Prospective Clinical Trial from Two Centers.
    Zuhdy M, Elmore U, Shams N, Hegazy MAF, Roshdy S, Eldamshety O, Metwally IH, Rosati R.
    J Laparoendosc Adv Surg Tech A; 2020 Jul 26; 30(7):769-776. PubMed ID: 32240035
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Three-year outcomes of transanal total mesorectal excision versus standard laparoscopic total mesorectal excision for mid and low rectal cancer.
    Zeng Z, Liu Z, Luo S, Liang Z, Huang L, Ruan L, Chen J, Jie H, Liang W, Liu H, Kang L.
    Surg Endosc; 2022 Jun 26; 36(6):3902-3910. PubMed ID: 34448933
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.